PO.CH02.02 · 化学

生态型指导的多组学分析鉴定胃癌中潜在的细胞表面治疗靶点

Ecotype-guided multi-omics profiling identifies potential cell-surface therapeutic targets in gastric cancer

海报缩略图:生态型指导的多组学分析鉴定胃癌中潜在的细胞表面治疗靶点
编号 7647 展板 1 时间 4/22 09:00–12:00 区域 Section 38 主讲 Yuefan Wang, Dr PH
分会场 Multi-Omics, Systems Biology, and Biological Mass Spectrometry
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Yuefan Wang1, Lindsey K. Olsen2, Hui Zhang1, Bing Zhang2, Clinical Proteomic Tumor Analysis Consortium (CPTAC)

1Pathology, Johns Hopkins University, Baltimore, MD,2Baylor College of Medicine, Houston, TX

摘要 Abstract

中文摘要
胃癌(GC)表现出显著的异质性、复杂的分子改变以及有限的治疗选择。为全面界定其生物学特性和易感性,我们对159例胃腺癌和30例匹配的癌旁正常组织进行了15层多组学分析,涵盖基因组学、表观基因组学、转录组学、蛋白质组学、翻译后修饰、蛋白-蛋白相互作用、代谢组学和微生物组分析,产生了超过385,000个特征。通过整合细胞状态解卷积,我们基于细胞状态定义了胃肿瘤生态型,为多组学整合提供了新框架。这些生态型捕获了不同的肿瘤生态系统和基质-免疫组成,并提供了比传统基因组或组织学分类更深入的机制见解。利用机器学习和大规模AI模型,我们鉴定了生态型特异性分子特征,并将其与临床结局相关联。为优先确定治疗机会,我们对蛋白和糖蛋白应用了高离群值分析。多个细胞表面相关靶点显示出强烈的高离群值表达,包括若干已知或新兴的治疗候选靶点。细胞外基质(ECM)成分在高离群值蛋白中显著富集,凸显了它们在肿瘤生长、侵袭和潜在治疗靶向中的核心作用。我们进一步表征了高离群值糖蛋白中改变的细胞表面糖基化模式,揭示了免疫调节和ECM结合方面的变化。磷酸化位点分辨分析鉴定了与侵袭性肿瘤行为相关的关键信号特征。重要的是,将这些高离群值事件嵌入生态型和基因组亚型框架中,揭示了单从基因组分类无法察觉的、不同的生态型特异性模式。单细胞分析将许多靶点定位于特定基质区室,特别是富含成纤维细胞的生态系统,提示靶向成纤维细胞驱动的微环境可能为侵袭性GC亚群提供新的治疗策略。总之,本研究建立了一种生态型指导的蛋白基因组学方法,将细胞表面蛋白、糖蛋白和信号节点提名为胃癌中的精准治疗候选靶点,并提供了一个广泛适用的模型,用于剖析其他复杂恶性肿瘤中的异质性。
查看英文原文 English abstract
Gastric cancer (GC) exhibits marked heterogeneity, complex molecular alterations, and limited therapeutic options. To comprehensively define its biology and vulnerabilities, we performed 15-layer multi-omics profiling of 159 gastric adenocarcinomas and 30 matched normal adjacent tissues, encompassing genomics, epigenomics, transcriptomics, proteomics, post-translational modifications, protein-protein interactions, metabolomics, and microbiome analyses, yielding more than 385,000 features. By integrating cell-state deconvolution, we defined gastric tumor ecotypes based on cellular states, providing a new framework for multi-omics integration. These ecotypes captured distinct tumor ecosystems and stromal-immune compositions and offered deeper mechanistic insight than conventional genomic or histologic classifications.Leveraging machine learning and large-scale AI models, we identified ecotype-specific molecular features and linked them to clinical outcome. To prioritize therapeutic opportunities, we applied high-outlier analysis to proteins and glycoproteins. Multiple cell-surface-associated targets showed strong high-outlier expression, including several known or emerging therapeutic candidates. Extracellular matrix (ECM) components were significantly enriched among high-outlier proteins, underscoring their central role in tumor growth, invasion, and potential therapeutic targeting. We further characterized altered cell-surface glycosylation patterns in high-outlier glycoproteins, revealing changes in immune regulation and ECM engagement. Phosphosite-resolved analysis identified key signaling signatures associated with aggressive tumor behavior.Importantly, embedding these high-outlier events within ecotype and genomic subtype frameworks revealed distinct, ecotype-specific patterns that were not apparent from genomic classification alone. Single-cell analyses localized many targets to specific stromal compartments, particularly fibroblast-rich ecosystems, suggesting that targeting fibroblast-driven niches may provide new therapeutic strategies for aggressive GC subsets. Overall, this study establishes an ecotype-guided proteogenomic approach to nominate cell-surface proteins, glycoproteins, and signaling nodes as precision therapy candidates in gastric cancer, and offers a broadly applicable model for dissecting heterogeneity in other complex malignancies.
利益披露 Disclosure
Y. Wang, None.. H. Zhang, None.

← 返回 AACR 2026 检索